232 related articles for article (PubMed ID: 7636268)
21. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells.
Taichman NS; Iwase M; Lally ET; Shattil SJ; Cunningham ME; Korchak HM
J Immunol; 1991 Nov; 147(10):3587-94. PubMed ID: 1940358
[TBL] [Abstract][Full Text] [Related]
22. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense.
Hadders MA; Beringer DX; Gros P
Science; 2007 Sep; 317(5844):1552-4. PubMed ID: 17872444
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
Cesano A; Visonneau S; Clark SC; Santoli D
J Immunol; 1993 Sep; 151(6):2943-57. PubMed ID: 8104216
[TBL] [Abstract][Full Text] [Related]
24. T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent.
Gruen M; Bommert K; Bargou RC
Cancer Immunol Immunother; 2004 Jul; 53(7):625-32. PubMed ID: 15175907
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
26. Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination.
Carney DF; Lang TJ; Shin ML
J Immunol; 1990 Jul; 145(2):623-9. PubMed ID: 2164064
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms of cytolysis by complement and by cytolytic lymphocytes.
Podack ER
J Cell Biochem; 1986; 30(2):133-70. PubMed ID: 2422185
[No Abstract] [Full Text] [Related]
28. Ca2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage.
Yoshida R; Sanchez-Bueno A; Yamamoto N; Einaga-Naito K
J Immunol; 1997 Jul; 159(1):15-21. PubMed ID: 9200433
[TBL] [Abstract][Full Text] [Related]
29. Impaired binding of perforin on the surface of tumor cells is a cause of target cell resistance against cytotoxic effector cells.
Lehmann C; Zeis M; Schmitz N; Uharek L
Blood; 2000 Jul; 96(2):594-600. PubMed ID: 10887123
[TBL] [Abstract][Full Text] [Related]
30. IL-4 induces protection of vascular endothelial cells against killing by complement and melittin through lipid biosynthesis.
Black SM; Schott ME; Batdorf BH; Benson BA; Rutherford MS; Levay-Young BK; Dalmasso AP
Eur J Immunol; 2010 Mar; 40(3):803-12. PubMed ID: 20017192
[TBL] [Abstract][Full Text] [Related]
31. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells.
DeBlaker-Hohe DF; Yamauchi A; Yu CR; Horvath-Arcidiacono JA; Bloom ET
Cell Immunol; 1995 Oct; 165(1):33-43. PubMed ID: 7671323
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
[TBL] [Abstract][Full Text] [Related]
33. T-cell cytotoxicity of human Schwann cells: TNFalpha promotes fasL-mediated apoptosis and IFN gamma perforin-mediated lysis.
Bonetti B; Valdo P; Ossi G; De Toni L; Masotto B; Marconi S; Rizzuto N; Nardelli E; Moretto G
Glia; 2003 Aug; 43(2):141-8. PubMed ID: 12838506
[TBL] [Abstract][Full Text] [Related]
34. Stably transfected antisense granzyme B and perforin constructs inhibit human granule-mediated lytic ability.
Bochan MR; Goebel WS; Brahmi Z
Cell Immunol; 1995 Sep; 164(2):234-9. PubMed ID: 7656332
[TBL] [Abstract][Full Text] [Related]
35. Heat-shocked A20 lymphoma cells fail to induce degranulation of cytotoxic T lymphocytes: possible mechanism of resistance.
Jackson KM; DeLeon M; Sistonen L; Verret CR
Cell Immunol; 2000 Jul; 203(1):12-8. PubMed ID: 10915557
[TBL] [Abstract][Full Text] [Related]
36. Human rheumatoid synovial cell stimulation by the membrane attack complex and other pore-forming toxins in vitro: the role of calcium in cell activation.
Daniels RH; Williams BD; Morgan BP
Immunology; 1990 Nov; 71(3):312-6. PubMed ID: 2269468
[TBL] [Abstract][Full Text] [Related]
37. Chimeric and truncated forms of human complement protein C8 alpha reveal binding sites for C8 beta and C8 gamma within the membrane attack complex/perforin region.
Plumb ME; Scibek JJ; Barber TD; Dunlap RJ; Platteborze PL; Sodetz JM
Biochemistry; 1999 Jun; 38(26):8478-84. PubMed ID: 10387094
[TBL] [Abstract][Full Text] [Related]
38. Mortalin inhibitors sensitize K562 leukemia cells to complement-dependent cytotoxicity.
Pilzer D; Saar M; Koya K; Fishelson Z
Int J Cancer; 2010 Mar; 126(6):1428-35. PubMed ID: 19739077
[TBL] [Abstract][Full Text] [Related]
39. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
[TBL] [Abstract][Full Text] [Related]
40. Calcium-dependent protection from complement lysis in Naegleria fowleri amebae.
Chu DM; Woodward J; Fritzinger A; Marciano-Cabral F
Cell Calcium; 2002 Mar; 31(3):105-14. PubMed ID: 12027384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
